Suchergebnisse - "Lema, Mauricio"

PubPharm (19)

1

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Llovet, J. | Kudo, M. | Merle, P. | +123

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547896

2

Real-world evidence of nivolumab for non-small-cell lung cancer in a developing country

enthalten in: Journal of investigative medicine : the official publication of the American Federation for Clinical Research | 2023

von Luján, M. | Lema, M. | Preciado, B. | +19

3

Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country : Results of the Epidemiological Registry of Malignant Melanoma in Colombia Study

enthalten in: JCO global oncology | 2023

von Ospina Serrano, A. | Contreras, F. | Triana, I. | +16

4

Concordance between 21-gene recurrence score assay and clinicopathological predictive models in early-breast cancer patients cared for at a cancer center in Colombia

enthalten in: Gaceta medica de Mexico | 2023

von Luján, M. | Morán, D. | Preciado, B. | +5

5

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country

enthalten in: Cancer control : journal of the Moffitt Cancer Center | 2023

von Cifuentes, C. | Lombana, M. | Vargas, H. | +38

6

Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America : an expert panel perspective

enthalten in: The Lancet. Oncology | 2022

von Teran, E. | Gomez, H. | Hannois, D. | +7

7

Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients : A Meta-Analysis of Randomized Clinical Trials

enthalten in: Biomedicines | 2022

von Manneh, R. | Lema, M. | Carril-Ajuria, L. | +4

8

NGS in Lung, Breast, and Unknown Primary Cancer in Colombia : A Multidisciplinary Consensus on Challenges and Opportunities

enthalten in: JCO global oncology | 2021

von Mantilla, W. | Sanabria-Salas, M. | Baldion, A. | +3

9

Management Costs of Febrile Neutropenia in Oncology Patients in Colombia

enthalten in: ResearchSquare.com | 2021

von Lema, M. | Preciado, B. | Quiceno, D. | +3

10

Personalizing Precision Oncology Clinical Trials in Latin America : An Expert Panel on Challenges and Opportunities

enthalten in: The oncologist | 2019

von Arai, R. | Guindalini, R. | Llera, A. | +9